Pharma & Healthcare
Global Inhaled Nitric Oxide Therapy Solutions Market Research Report 2025
- Jun 12, 25
- ID: 306712
- Pages: 62
- Figures: 61
- Views: 23
The global market for Inhaled Nitric Oxide Therapy Solutions was valued at US$ 910 million in the year 2024 and is projected to reach a revised size of US$ 1441 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Inhaled Nitric Oxide (iNO) therapy is a medical treatment that involves the delivery of nitric oxide (NO) gas directly to the lungs of patients, thereby improving gas exchange and oxygenation in the respiratory system. It is commonly used to treat acute respiratory distress syndrome (ARDS) in both neonates and adults, pulmonary hypertension, and other respiratory diseases. The primary objective of iNO therapy is to enhance pulmonary blood flow by dilating blood vessels in the lungs through the vasodilatory effect of nitric oxide, thereby reducing pulmonary vascular resistance and improving oxygen transfer to maintain normal oxygenation levels.
Nitric oxide itself is a potent vasodilator and its medical use dates back to the 1990s. Inhaled NO acts locally on the pulmonary vasculature, selectively dilating the small blood vessels in the lungs and reducing the load on the right side of the heart, which in turn helps improve blood oxygen levels in hypoxemic patients. The therapy is typically administered using specialized equipment, such as iNO delivery devices, which can be administered via masks, breathing tubes, or nasal cannulas. This treatment not only alleviates symptoms of acute respiratory distress syndrome but also effectively reduces complications associated with pulmonary hypertension.
The product range includes iNO generation systems, gas delivery systems, concentration regulators, and monitoring devices. The generation system is the core of the treatment, responsible for safely and steadily producing nitric oxide gas at clinically acceptable purity levels. The delivery system ensures that the nitric oxide is delivered to the patient's airways at the correct concentration and flow rate. Monitoring equipment is used to continuously track the patient's blood oxygen levels, gas concentrations, and other physiological parameters to ensure the treatment is both effective and safe.
The inhaled nitric oxide (iNO) therapy market is growing rapidly, particularly in the treatment of respiratory diseases. With the increasing prevalence of chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), pulmonary hypertension, and other respiratory illnesses, the demand for this therapy is on the rise. Inhaled nitric oxide, due to its ability to improve pulmonary microvascular blood flow, has become a key component of treatment plans for many critically ill patients. It is especially regarded as a first-line therapy for neonates and children.
From a market development perspective, the primary driving force is the growing need for effective treatments for respiratory diseases, particularly in emerging markets and developing countries. Additionally, ongoing technological advancements in nitric oxide generation and delivery systems, making them more convenient, precise, and safe, have propelled market growth. The global aging population and the increasing incidence of respiratory diseases due to environmental pollution further exacerbate the demand for iNO therapy.
However, the market also faces several challenges and risks. First, the cost of iNO therapy is relatively high, which poses a significant economic burden for healthcare institutions, especially in developing countries. Second, despite its effectiveness, the use of nitric oxide requires strict monitoring and administration, which may increase the complexity and difficulty of managing treatment in healthcare settings. Additionally, the supply and quality control of nitric oxide gas are potential risks; instability or poor-quality supply can severely impact treatment effectiveness and safety.
The market concentration is relatively high, with a few leading companies dominating innovation and production in this field. These include global medical device manufacturers specializing in respiratory therapy. Furthermore, there is a noticeable trend of innovation and research and development in inhaled nitric oxide delivery devices, and the market is expected to continue advancing toward more efficient, safer, and more convenient solutions, particularly in areas such as personalized treatment, remote monitoring, and smart devices.
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide Therapy Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide Therapy Solutions.
The Inhaled Nitric Oxide Therapy Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhaled Nitric Oxide Therapy Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Nitric Oxide Therapy Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt
Linde
Air Liquide
Segment by Type
iNO Gas
Inhaled Nitric Oxide Delivery System
Segment by Application
Hospitals
Other Healthcare System
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inhaled Nitric Oxide Therapy Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Inhaled Nitric Oxide (iNO) therapy is a medical treatment that involves the delivery of nitric oxide (NO) gas directly to the lungs of patients, thereby improving gas exchange and oxygenation in the respiratory system. It is commonly used to treat acute respiratory distress syndrome (ARDS) in both neonates and adults, pulmonary hypertension, and other respiratory diseases. The primary objective of iNO therapy is to enhance pulmonary blood flow by dilating blood vessels in the lungs through the vasodilatory effect of nitric oxide, thereby reducing pulmonary vascular resistance and improving oxygen transfer to maintain normal oxygenation levels.
Nitric oxide itself is a potent vasodilator and its medical use dates back to the 1990s. Inhaled NO acts locally on the pulmonary vasculature, selectively dilating the small blood vessels in the lungs and reducing the load on the right side of the heart, which in turn helps improve blood oxygen levels in hypoxemic patients. The therapy is typically administered using specialized equipment, such as iNO delivery devices, which can be administered via masks, breathing tubes, or nasal cannulas. This treatment not only alleviates symptoms of acute respiratory distress syndrome but also effectively reduces complications associated with pulmonary hypertension.
The product range includes iNO generation systems, gas delivery systems, concentration regulators, and monitoring devices. The generation system is the core of the treatment, responsible for safely and steadily producing nitric oxide gas at clinically acceptable purity levels. The delivery system ensures that the nitric oxide is delivered to the patient's airways at the correct concentration and flow rate. Monitoring equipment is used to continuously track the patient's blood oxygen levels, gas concentrations, and other physiological parameters to ensure the treatment is both effective and safe.
The inhaled nitric oxide (iNO) therapy market is growing rapidly, particularly in the treatment of respiratory diseases. With the increasing prevalence of chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), pulmonary hypertension, and other respiratory illnesses, the demand for this therapy is on the rise. Inhaled nitric oxide, due to its ability to improve pulmonary microvascular blood flow, has become a key component of treatment plans for many critically ill patients. It is especially regarded as a first-line therapy for neonates and children.
From a market development perspective, the primary driving force is the growing need for effective treatments for respiratory diseases, particularly in emerging markets and developing countries. Additionally, ongoing technological advancements in nitric oxide generation and delivery systems, making them more convenient, precise, and safe, have propelled market growth. The global aging population and the increasing incidence of respiratory diseases due to environmental pollution further exacerbate the demand for iNO therapy.
However, the market also faces several challenges and risks. First, the cost of iNO therapy is relatively high, which poses a significant economic burden for healthcare institutions, especially in developing countries. Second, despite its effectiveness, the use of nitric oxide requires strict monitoring and administration, which may increase the complexity and difficulty of managing treatment in healthcare settings. Additionally, the supply and quality control of nitric oxide gas are potential risks; instability or poor-quality supply can severely impact treatment effectiveness and safety.
The market concentration is relatively high, with a few leading companies dominating innovation and production in this field. These include global medical device manufacturers specializing in respiratory therapy. Furthermore, there is a noticeable trend of innovation and research and development in inhaled nitric oxide delivery devices, and the market is expected to continue advancing toward more efficient, safer, and more convenient solutions, particularly in areas such as personalized treatment, remote monitoring, and smart devices.
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide Therapy Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide Therapy Solutions.
The Inhaled Nitric Oxide Therapy Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhaled Nitric Oxide Therapy Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Nitric Oxide Therapy Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt
Linde
Air Liquide
Segment by Type
iNO Gas
Inhaled Nitric Oxide Delivery System
Segment by Application
Hospitals
Other Healthcare System
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inhaled Nitric Oxide Therapy Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 iNO Gas
1.2.3 Inhaled Nitric Oxide Delivery System
1.3 Market by Application
1.3.1 Global Inhaled Nitric Oxide Therapy Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Other Healthcare System
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inhaled Nitric Oxide Therapy Solutions Market Perspective (2020-2031)
2.2 Global Inhaled Nitric Oxide Therapy Solutions Growth Trends by Region
2.2.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Inhaled Nitric Oxide Therapy Solutions Historic Market Size by Region (2020-2025)
2.2.3 Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Region (2026-2031)
2.3 Inhaled Nitric Oxide Therapy Solutions Market Dynamics
2.3.1 Inhaled Nitric Oxide Therapy Solutions Industry Trends
2.3.2 Inhaled Nitric Oxide Therapy Solutions Market Drivers
2.3.3 Inhaled Nitric Oxide Therapy Solutions Market Challenges
2.3.4 Inhaled Nitric Oxide Therapy Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inhaled Nitric Oxide Therapy Solutions Players by Revenue
3.1.1 Global Top Inhaled Nitric Oxide Therapy Solutions Players by Revenue (2020-2025)
3.1.2 Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Top Inhaled Nitric Oxide Therapy Solutions Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Inhaled Nitric Oxide Therapy Solutions Revenue
3.4 Global Inhaled Nitric Oxide Therapy Solutions Market Concentration Ratio
3.4.1 Global Inhaled Nitric Oxide Therapy Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inhaled Nitric Oxide Therapy Solutions Revenue in 2024
3.5 Global Key Players of Inhaled Nitric Oxide Therapy Solutions Head office and Area Served
3.6 Global Key Players of Inhaled Nitric Oxide Therapy Solutions, Product and Application
3.7 Global Key Players of Inhaled Nitric Oxide Therapy Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Inhaled Nitric Oxide Therapy Solutions Breakdown Data by Type
4.1 Global Inhaled Nitric Oxide Therapy Solutions Historic Market Size by Type (2020-2025)
4.2 Global Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Type (2026-2031)
5 Inhaled Nitric Oxide Therapy Solutions Breakdown Data by Application
5.1 Global Inhaled Nitric Oxide Therapy Solutions Historic Market Size by Application (2020-2025)
5.2 Global Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Inhaled Nitric Oxide Therapy Solutions Market Size (2020-2031)
6.2 North America Inhaled Nitric Oxide Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025)
6.4 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inhaled Nitric Oxide Therapy Solutions Market Size (2020-2031)
7.2 Europe Inhaled Nitric Oxide Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025)
7.4 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size (2020-2031)
8.2 Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inhaled Nitric Oxide Therapy Solutions Market Size (2020-2031)
9.2 Latin America Inhaled Nitric Oxide Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025)
9.4 Latin America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size (2020-2031)
10.2 Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mallinckrodt
11.1.1 Mallinckrodt Company Details
11.1.2 Mallinckrodt Business Overview
11.1.3 Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Introduction
11.1.4 Mallinckrodt Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
11.1.5 Mallinckrodt Recent Development
11.2 Linde
11.2.1 Linde Company Details
11.2.2 Linde Business Overview
11.2.3 Linde Inhaled Nitric Oxide Therapy Solutions Introduction
11.2.4 Linde Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
11.2.5 Linde Recent Development
11.3 Air Liquide
11.3.1 Air Liquide Company Details
11.3.2 Air Liquide Business Overview
11.3.3 Air Liquide Inhaled Nitric Oxide Therapy Solutions Introduction
11.3.4 Air Liquide Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
11.3.5 Air Liquide Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 iNO Gas
1.2.3 Inhaled Nitric Oxide Delivery System
1.3 Market by Application
1.3.1 Global Inhaled Nitric Oxide Therapy Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Other Healthcare System
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inhaled Nitric Oxide Therapy Solutions Market Perspective (2020-2031)
2.2 Global Inhaled Nitric Oxide Therapy Solutions Growth Trends by Region
2.2.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Inhaled Nitric Oxide Therapy Solutions Historic Market Size by Region (2020-2025)
2.2.3 Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Region (2026-2031)
2.3 Inhaled Nitric Oxide Therapy Solutions Market Dynamics
2.3.1 Inhaled Nitric Oxide Therapy Solutions Industry Trends
2.3.2 Inhaled Nitric Oxide Therapy Solutions Market Drivers
2.3.3 Inhaled Nitric Oxide Therapy Solutions Market Challenges
2.3.4 Inhaled Nitric Oxide Therapy Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inhaled Nitric Oxide Therapy Solutions Players by Revenue
3.1.1 Global Top Inhaled Nitric Oxide Therapy Solutions Players by Revenue (2020-2025)
3.1.2 Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Top Inhaled Nitric Oxide Therapy Solutions Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Inhaled Nitric Oxide Therapy Solutions Revenue
3.4 Global Inhaled Nitric Oxide Therapy Solutions Market Concentration Ratio
3.4.1 Global Inhaled Nitric Oxide Therapy Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inhaled Nitric Oxide Therapy Solutions Revenue in 2024
3.5 Global Key Players of Inhaled Nitric Oxide Therapy Solutions Head office and Area Served
3.6 Global Key Players of Inhaled Nitric Oxide Therapy Solutions, Product and Application
3.7 Global Key Players of Inhaled Nitric Oxide Therapy Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Inhaled Nitric Oxide Therapy Solutions Breakdown Data by Type
4.1 Global Inhaled Nitric Oxide Therapy Solutions Historic Market Size by Type (2020-2025)
4.2 Global Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Type (2026-2031)
5 Inhaled Nitric Oxide Therapy Solutions Breakdown Data by Application
5.1 Global Inhaled Nitric Oxide Therapy Solutions Historic Market Size by Application (2020-2025)
5.2 Global Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Inhaled Nitric Oxide Therapy Solutions Market Size (2020-2031)
6.2 North America Inhaled Nitric Oxide Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025)
6.4 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inhaled Nitric Oxide Therapy Solutions Market Size (2020-2031)
7.2 Europe Inhaled Nitric Oxide Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025)
7.4 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size (2020-2031)
8.2 Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inhaled Nitric Oxide Therapy Solutions Market Size (2020-2031)
9.2 Latin America Inhaled Nitric Oxide Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025)
9.4 Latin America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size (2020-2031)
10.2 Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mallinckrodt
11.1.1 Mallinckrodt Company Details
11.1.2 Mallinckrodt Business Overview
11.1.3 Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Introduction
11.1.4 Mallinckrodt Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
11.1.5 Mallinckrodt Recent Development
11.2 Linde
11.2.1 Linde Company Details
11.2.2 Linde Business Overview
11.2.3 Linde Inhaled Nitric Oxide Therapy Solutions Introduction
11.2.4 Linde Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
11.2.5 Linde Recent Development
11.3 Air Liquide
11.3.1 Air Liquide Company Details
11.3.2 Air Liquide Business Overview
11.3.3 Air Liquide Inhaled Nitric Oxide Therapy Solutions Introduction
11.3.4 Air Liquide Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
11.3.5 Air Liquide Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of iNO Gas
Table 3. Key Players of Inhaled Nitric Oxide Delivery System
Table 4. Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Region (2020-2025)
Table 8. Global Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Region (2026-2031)
Table 10. Inhaled Nitric Oxide Therapy Solutions Market Trends
Table 11. Inhaled Nitric Oxide Therapy Solutions Market Drivers
Table 12. Inhaled Nitric Oxide Therapy Solutions Market Challenges
Table 13. Inhaled Nitric Oxide Therapy Solutions Market Restraints
Table 14. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Players (2020-2025)
Table 16. Global Top Inhaled Nitric Oxide Therapy Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide Therapy Solutions as of 2024)
Table 17. Ranking of Global Top Inhaled Nitric Oxide Therapy Solutions Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Inhaled Nitric Oxide Therapy Solutions Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Inhaled Nitric Oxide Therapy Solutions, Headquarters and Area Served
Table 20. Global Key Players of Inhaled Nitric Oxide Therapy Solutions, Product and Application
Table 21. Global Key Players of Inhaled Nitric Oxide Therapy Solutions, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Type (2020-2025)
Table 25. Global Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Type (2026-2031)
Table 27. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Application (2020-2025)
Table 29. Global Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Application (2026-2031)
Table 31. North America Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 46. Mallinckrodt Company Details
Table 47. Mallinckrodt Business Overview
Table 48. Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Product
Table 49. Mallinckrodt Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025) & (US$ Million)
Table 50. Mallinckrodt Recent Development
Table 51. Linde Company Details
Table 52. Linde Business Overview
Table 53. Linde Inhaled Nitric Oxide Therapy Solutions Product
Table 54. Linde Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025) & (US$ Million)
Table 55. Linde Recent Development
Table 56. Air Liquide Company Details
Table 57. Air Liquide Business Overview
Table 58. Air Liquide Inhaled Nitric Oxide Therapy Solutions Product
Table 59. Air Liquide Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025) & (US$ Million)
Table 60. Air Liquide Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report
List of Figures
Figure 1. Inhaled Nitric Oxide Therapy Solutions Picture
Figure 2. Global Inhaled Nitric Oxide Therapy Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Type: 2024 VS 2031
Figure 4. iNO Gas Features
Figure 5. Inhaled Nitric Oxide Delivery System Features
Figure 6. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Other Healthcare System Case Studies
Figure 10. Inhaled Nitric Oxide Therapy Solutions Report Years Considered
Figure 11. Global Inhaled Nitric Oxide Therapy Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Inhaled Nitric Oxide Therapy Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Region: 2024 VS 2031
Figure 14. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Players in 2024
Figure 15. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Inhaled Nitric Oxide Therapy Solutions Revenue in 2024
Figure 17. North America Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2020-2031)
Figure 19. United States Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2020-2031)
Figure 23. Germany Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Share by Region (2020-2031)
Figure 31. China Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2020-2031)
Figure 39. Mexico Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2020-2031)
Figure 43. Turkey Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Mallinckrodt Revenue Growth Rate in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
Figure 47. Linde Revenue Growth Rate in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
Figure 48. Air Liquide Revenue Growth Rate in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Table 1. Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of iNO Gas
Table 3. Key Players of Inhaled Nitric Oxide Delivery System
Table 4. Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Region (2020-2025)
Table 8. Global Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Region (2026-2031)
Table 10. Inhaled Nitric Oxide Therapy Solutions Market Trends
Table 11. Inhaled Nitric Oxide Therapy Solutions Market Drivers
Table 12. Inhaled Nitric Oxide Therapy Solutions Market Challenges
Table 13. Inhaled Nitric Oxide Therapy Solutions Market Restraints
Table 14. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Players (2020-2025)
Table 16. Global Top Inhaled Nitric Oxide Therapy Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide Therapy Solutions as of 2024)
Table 17. Ranking of Global Top Inhaled Nitric Oxide Therapy Solutions Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Inhaled Nitric Oxide Therapy Solutions Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Inhaled Nitric Oxide Therapy Solutions, Headquarters and Area Served
Table 20. Global Key Players of Inhaled Nitric Oxide Therapy Solutions, Product and Application
Table 21. Global Key Players of Inhaled Nitric Oxide Therapy Solutions, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Type (2020-2025)
Table 25. Global Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Type (2026-2031)
Table 27. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Application (2020-2025)
Table 29. Global Inhaled Nitric Oxide Therapy Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Application (2026-2031)
Table 31. North America Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2026-2031) & (US$ Million)
Table 46. Mallinckrodt Company Details
Table 47. Mallinckrodt Business Overview
Table 48. Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Product
Table 49. Mallinckrodt Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025) & (US$ Million)
Table 50. Mallinckrodt Recent Development
Table 51. Linde Company Details
Table 52. Linde Business Overview
Table 53. Linde Inhaled Nitric Oxide Therapy Solutions Product
Table 54. Linde Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025) & (US$ Million)
Table 55. Linde Recent Development
Table 56. Air Liquide Company Details
Table 57. Air Liquide Business Overview
Table 58. Air Liquide Inhaled Nitric Oxide Therapy Solutions Product
Table 59. Air Liquide Revenue in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025) & (US$ Million)
Table 60. Air Liquide Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report
List of Figures
Figure 1. Inhaled Nitric Oxide Therapy Solutions Picture
Figure 2. Global Inhaled Nitric Oxide Therapy Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Type: 2024 VS 2031
Figure 4. iNO Gas Features
Figure 5. Inhaled Nitric Oxide Delivery System Features
Figure 6. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Other Healthcare System Case Studies
Figure 10. Inhaled Nitric Oxide Therapy Solutions Report Years Considered
Figure 11. Global Inhaled Nitric Oxide Therapy Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Inhaled Nitric Oxide Therapy Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Region: 2024 VS 2031
Figure 14. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Players in 2024
Figure 15. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Inhaled Nitric Oxide Therapy Solutions Revenue in 2024
Figure 17. North America Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2020-2031)
Figure 19. United States Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2020-2031)
Figure 23. Germany Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Market Share by Region (2020-2031)
Figure 31. China Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2020-2031)
Figure 39. Mexico Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2020-2031)
Figure 43. Turkey Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Inhaled Nitric Oxide Therapy Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Mallinckrodt Revenue Growth Rate in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
Figure 47. Linde Revenue Growth Rate in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
Figure 48. Air Liquide Revenue Growth Rate in Inhaled Nitric Oxide Therapy Solutions Business (2020-2025)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232